Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
The use of psychostimulants to treat attention-deficit/hyperactivity disorder (ADHD) has been controversial for a number of reasons. In an effort to clarify the extent to which the psychostimulant methylphenidate has abuse potential, the existing published evidence has been reviewed and is summarized here, with an emphasis on delineating a number of related but independent issues that are often confused. Methylphenidate produces behavioral effects associated with abuse potential as assessed by traditional assays, but the relevance of this literature to the clinical use of the drug in the treatment of ADHD is ambiguous at best. Existing neuropharmacologic data suggest that methylphenidate has pharmacokinetic properties that reduce its abuse potential as compared with other stimulant drugs of abuse, such as cocaine.
Kollins
Scott H
SH
Duke Child and Family Study Center, Duke University Medical Center, Durham, NC 27705, USA. kolli001@mc.duke.edu
D000328:Adult; D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D003042:Cocaine / Q000493:pharmacokinetics; D003913:Dextroamphetamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012054:Reinforcement, Psychology; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003042:Cocaine; D003913:Dextroamphetamine